Insider filing · ORKA
Paul T Quinlan
General Counsel
profile →
Oruka Therapeutics, Inc.
ORKA · Healthcare · 32 filings in 24 months
ticker →
Paul T Quinlan sold $880K of Oruka Therapeutics (ORKA)
Executed Sep 21, disclosed Sep 21, the same day.
Value, as filed
$880K
9,399 sh across 3 lots
Executed
Sep 21
the trade date, as filed
Disclosed
Sep 21
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PQPaul T Quinlan (General Counsel) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $5.6M of ORKA (52,000 sh across 6 lots, as filed), executed Aug 14.
The name
ORKAHealthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Paul T Quinlan in ORKA
ORKASALE
Oruka Therapeutics, Inc.
$562K7,100 sh across 2 lots
Exec Oct 20
Filed Oct 20 · 8:42 PM ET ORKASALE Oruka Therapeutics, Inc. $5.6M
52,000 sh across 6 lots
Exec Aug 14
Filed Aug 14 · 5:52 PM ET